On May 5, 2015, The European Institute, in cooperation with the French Ministry of Interior, convened a workshop on the evolution of terrorist financing with leading experts in the field, including The Honorable Jean-Louis Bruguière, former High Representative of the European EU to the U.S. for the Fight against Financing of Terrorism within the framework of “Terrorism Finance Tracking Program/SWIFT”; Ismael Nevares, Jr., Narcotics and Counterterrorism Director at the IRS’s Criminal Investigations unit; Jean-Baptiste Carpentier, Director of TRACFIN at the French Ministry of Finance, and Jean Denis Pesme, Manager of the Financial Market Integrity team and Coordinator of the Stolen Asset Recovery Initiative at the World Bank.
Since July 1st, Croatia’s tenure as the newest member state on the European Union has been overshadowed by an open confrontation with Brussels over Zagreb’s application of the European Arrest Warrant (EAW). Three days before official entry into the EU, the Croatian Parliament adopted changes preventing the extradition of anyone suspected of committing a crime before August 7, 2002. Unofficially known as Lex Perkovic, in reference to Josip Perkovic, the former head of Croatian intelligence, whose extradition is being sought by Germany for his involvement in the 1983 assassination of a Croatian dissident. Croatia has received 23 extradition requests from other EU nations, dating back before 2002, that fall under the European Arrest Warrant Framework Decision.
On October 25, 2012, The European Institute, in cooperation with the Embassy of Belgium and the Embassy of Switzerland held a special seminar on transatlantic cooperation in stemming the spread of falsified medications. Mark Witzal, Deputy Director of the National Intellectual Property Rights Coordination Center, U.S. Immigrations and Customs Enforcement, Homeland Security Investigations presented the keynote address. Panelists in the first session: Bernard Frahi, Vice President for Corporate Economic Security at Sanofi; Ambassador Richard Kauzlarich, Deputy Director at the Terrorism, Transnational Crime & Corruption Center and Adjunct Professor at George Mason University’s School of Public Policy; and Jeffrey Gren, Director of the Office of Health and Consumer Goods at the U.S. Department of Commerce discussed the security, economic and public health risks of falsified medications. The panel was moderated by Susan Reardon, Director of International Policy, Worldwide Government Affairs and Policy at Johnson & Johnson. Panelists in the second session: John Roth, Director of the Office of Criminal Investigations at the U.S. Food and Drug Administration; Patrick Byrne, Europol Senior Representative and Head of Europol Delegation at the Delegation of the European Union to the United States; Chief Commissioner Patrick Stevens, Counselor and Belgian Police Liaison Officer at the Embassy of Belgium; Kelley Friedgen, Senior Corporate Counsel at Genentech and Legal Advisor to the Genentech Counterfeit Prevention and Response Task Force; and Jeannie Salo, Director for Global Anti-Counterfeiting, Office of International Government Affairs at Eli Lilly and Company examined public and private sector solutions to the fast-growing falsified medications problem. This panel was moderated by Frédéric Badey, Senior Director, International Public Affairs Coordination, Sanofi.
European Union Justice Commissioner Viviane Reding is proposing draft legislation that would require state owned companies to name women to 40 percent of seats on boards by 2018. According to the European Commission women hold only14 percent of board member positions and 3 percent of board president positions in Europe’s biggest companies, despite the fact that around 60% of all European university graduates are female. “I do not accept the argument that there aren’t enough qualified women to fill supervisory boards,” Reding said. “The pool of talent is there. Companies should make use of it.”
The EU has made more headlines in the American media this year than perhaps at any time in its history. With markets and governments jittery about the future of the EU single currency, the euro, there has been a flurry of EU summits peppered with seemingly endless talks on bailout terms and treaty changes. And the future of the EU has been in play.
© COPYRIGHT THE EUROPEAN INSTITUTE 2009
You may share using our article tools. Please don't cut articles from our site and redistribute by email or post to the web.